01Sec
Section 1 of 5
Drug Dosages — Adult & Pediatric
35 questions covering every drug in P-115 and P-117 — adult doses, pediatric doses, max limits, and route-specific rules.
Q1
Protocol ReferenceP-115 Acetaminophen: Adult = 1,000 mg IV over 15 min. Pediatric = per drug chart (15 mg/kg, max 1 gm) in 100 mL NS over 15 min. Contraindicated in <2 years.
Q2
Protocol ReferenceP-117 Drug Chart: Acetaminophen IV = 15 mg/kg, max single dose 1 gm, in 100 mL NS over 15 min. Contraindicated in patients <2 years of age.
Q3
Protocol ReferenceP-115 Adenosine: 6 mg rapid IV/IO + 20 mL NS rapid flush. If no conversion: 12 mg rapid IV/IO + 20 mL NS flush, MR x1. Peds: per drug chart (0.1 mg/kg 1st dose, 0.2 mg/kg 2nd/3rd), max 6 mg/12 mg, MR x2.
Q4
Protocol ReferenceP-115 Albuterol/Levalbuterol: Adult = 6 mL via nebulizer, MR. For hyperkalemia/crush: continuous nebulization. Pediatric = per drug chart (albuterol 5 mg fixed, levalbuterol age-based). Levalbuterol contraindicated <6 years.
Q5
Protocol ReferenceP-115 Amiodarone: VF/pVT = 300 mg IV/IO, MR 150 mg q3-5 min (max 450 mg). Stable VT = 150 mg in 100 mL NS over 10 min IV/IO, MR x1. Peds VF/pVT = 5 mg/kg IV/IO, max 150 mg per drug chart.
Q6
Protocol ReferenceP-115 Aspirin: Paramedic dose = 324 mg chewable PO. EMTs may assist patient self-medicate own prescribed aspirin up to 325 mg. Not indicated in pediatrics.
Q7
Protocol ReferenceP-115 Atropine: Unstable bradycardia = 1 mg IV/IO, MR q3-5 min, max 3 mg. Organophosphate = start 2 mg IV/IO, then double prior dose q3-5 min for continued SLUDGE/BBB signs. Peds bradycardia: per drug chart (0.02 mg/kg, max 0.5 mg/2 mg) after 3 epi doses.
Q8
Protocol ReferenceP-115 Calcium Chloride: Adult = 1 gm IV/IO for hyperkalemia (widened QRS, PEA), calcium channel blocker OD, or crush injury (over 30 sec). Peds = 20 mg/kg IV/IO, max 500 mg, MR x1 in 5 min for continued ECG findings.
Q9
Protocol ReferenceP-115/P-117 Dextrose: Adult = 25 gm IV if BS <60 mg/dL, MR if remains symptomatic. Peds = D10 per drug chart (0.5 gm/kg, max 25 gm) if BS <60 mg/dL (<45 mg/dL for neonates), MR if remains symptomatic.
Q10
Protocol ReferenceP-115 Diphenhydramine: Adult = 50 mg IV/IM (administer slow IV). Peds = per drug chart (1 mg/kg, max 50 mg) IV/IM.
Q11
Protocol ReferenceP-115 Epi 1:1,000: Adult = 0.5 mg IM, MR x2 q5 min. Peds IM = 0.01 mg/kg, max 0.3 mg, MR x2 q5 min. Peds nebulized = 2.5–5 mg (1:1,000 + 3 mL NS), MR x1.
Q12
Protocol ReferenceP-115 Epi 1:10,000: Adult cardiac arrest = 1 mg IV/IO q3-5 min. VF/pVT: begin after 2nd defibrillation. Hypothermia arrest: 1 mg x1 only. Peds: 0.01 mg/kg IV/IO (max 1 mg) q3-5 min per drug chart.
Q13
Protocol ReferenceP-115 Epi 1:100,000 (push-dose): Adult = 1 mL IV/IO MR q3 min, titrate to SBP ≥90 mmHg. Mixed by adding 1 mL of 1:10,000 epi to 9 mL NS → 10 mcg/mL. Peds = per drug chart (0.001 mg/kg, max 0.01 mg), titrate to adequate perfusion.
Q14
Protocol ReferenceP-115 Fentanyl: Adult IV = up to 100 mcg, MR 50 mcg q5 min x2 (max 200 mcg). IN = up to 50 mcg q15 min x2 (3rd dose 50 mcg also allowed). Peds <10 kg: IV 1 mcg/kg (max 10 mcg), IN 1 mcg/kg (max 10 mcg). Peds ≥10 kg: IV 1 mcg/kg (max 100 mcg), IN 1.5 mcg/kg (max 50 mcg).
Q15
Protocol ReferenceP-115 Glucagon: Hypoglycemia adult = 1 mL IM. Beta blocker OD = 1–5 mg IV, MR q5-10 min, max 10 mg total. Peds = per drug chart IM (0.05 mg/kg, max 1 mg).
Q16
Protocol ReferenceP-115 Ipratropium: Adult = 2.5 mL 0.02% via nebulizer ADDED to first dose of albuterol/levalbuterol only. Peds = per drug chart (0.5 mg/2.5 mL), also combined with first albuterol dose only.
Q17
Protocol ReferenceP-115 Ketamine (sub-dissociative): IV = 0.3 mg/kg in 100 mL NS over 10 min, max 30 mg per dose, MR x1 at 15 min. IN = 0.5 mg/kg (50 mg/mL), max 50 mg per dose, MR x1 at 15 min. Do NOT exceed 60 mg IV or 100 mg IN total. Not indicated in peds.
Q18
Protocol ReferenceP-115 Lidocaine: Adult dysrhythmia = 1.5 mg/kg IV/IO, MR 0.5 mg/kg q5 min, max 3 mg/kg. Conscious adult IO procedure = 40 mg IO slow. Peds VF/pVT per drug chart (1 mg/kg, max not applicable — use drug chart).
Q19
Protocol ReferenceP-115 Midazolam Seizure: ≥40 kg = 10 mg IM. <40 kg = 0.2 mg/kg IM. If IV access: 0.2 mg/kg IV/IO max 5 mg, MR x1 in 10 min, max 10 mg total. Behavioral adult: 5 mg IM/IN/IV, MR x1 in 5-10 min. Pre-cardioversion: 1–5 mg IV/IO.
Q20
Protocol ReferenceP-115 Midazolam indications: Unable to tolerate CPAP = 0.5–1 mg IM/IN/IV. Intubated with agitation = 2–5 mg IM/IN/IV/IO, MR x1 in 5-10 min. Behavioral = 5 mg IM/IN/IV, MR x1 in 5-10 min. Pre-cardioversion/pacing = 1–5 mg IV/IO.
Q21
Protocol ReferenceP-115 Morphine: Adult IV = up to 0.1 mg/kg IV, MR half initial dose at 5 min, MR half initial dose at additional 5 min. Adult IM = up to 0.1 mg/kg IM, MR half initial dose at 15 min, MR half again at additional 15 min. Peds = per drug chart (0.1 mg/kg, max 4 mg) IV/IM.
Q22
Protocol ReferenceP-115 Naloxone: Adult = 2 mg IN/IM/IV MR, OR 4 mg nasal spray preloaded device. NOT authorized in cardiac arrest. If patient refuses transport: additional 2 mg IM or 4 mg nasal spray. Peds = per drug chart IN/IV/IM, MR.
Q23
Protocol ReferenceP-115 Nitroglycerin: Cardiac chest pain SBP ≥100 = 0.4 mg SL MR q3-5 min. CHF SBP ≥100 but <150 = 0.4 mg SL MR q3-5 min. CHF SBP ≥150 = 0.8 mg SL MR q3-5 min. Contraindicated if ED/PH meds within 48 hr or suspected intracranial bleed. Not for peds.
Q24
Protocol ReferenceP-115 Ondansetron: Adult = 4 mg IV/IM/ODT, MR x1 in 10 min. Contraindicated in <6 months or known long QT syndrome. Peds per drug chart: <6 mo = contraindicated; 6 mo–3 yr = 2 mg; >3 yr = 4 mg IM/IV/ODT.
Q25
Protocol ReferenceP-115 Sodium Bicarbonate: Adult = 1 mEq/kg IV/IO. Indications: hyperkalemia, TCA overdose, crush injuries. Peds = per drug chart (1 mEq/kg, max 50 mEq) IV/IO. Do NOT mix with calcium chloride — flush line between.
Q26
Protocol ReferenceP-115 TXA: 1 gm/10 mL IV/IO in 50–100 mL NS over 10 min. Contraindicated if mechanism/delivery >3 hrs prior, isolated severe head injury, thromboembolic event within 24 hrs, or potential need for reimplantation. Not indicated in peds.
Q27
Protocol ReferenceP-115 Buprenorphine-Naloxone: Initial = 16 mg/4 mg SL (BHO). For continued symptoms, repeat 8 mg/2 mg SL, max 24 mg/6 mg total. Contraindicated <16 years, methadone use within 10 days, AMS, or severe illness. Only authorized at agencies in the Buprenorphine Pilot Program.
Q28
Protocol ReferenceP-117 Peds Drug Chart: Adenosine 1st dose = 0.1 mg/kg rapid IV/IO + 20 mL NS flush, max 6 mg. 2nd/3rd dose = 0.2 mg/kg rapid IV/IO + flush, max 12 mg. MR x2.
Q29
Protocol ReferenceP-117 Peds Drug Chart: Epi 1:10,000 cardiac arrest/newborn HR <60 = 0.01 mg/kg IV/IO q3-5 min, max 1 mg. VF/pVT: begin after 2nd defibrillation. Hypothermia: 0.01 mg/kg x1 only. Unstable bradycardia: 0.01 mg/kg, MR x2 q3-5 min, MR BHO.
Q30
Protocol ReferenceP-117 Fentanyl Peds ≥10 kg: IV = 1 mcg/kg (max 100 mcg), MR at half initial IV dose. IN = 1.5 mcg/kg (max 50 mcg), MR at initial IN dose. Peds <10 kg: IV = 1 mcg/kg (max 10 mcg), IN = 1 mcg/kg (max 10 mcg), MR BHO.
Q31
Protocol ReferenceP-117 Midazolam Peds: Seizure IM = 0.2 mg/kg, max 5 mg. Seizure IV/IO slow = 0.1 mg/kg, max 5 mg, MR x1 in 10 min. Behavioral IM/IN/IV = per drug chart, MR x1 in 10 min. Pre-cardioversion = per drug chart IV/IO.
Q32
Protocol ReferenceP-117 Atropine Peds: Bradycardia = 0.02 mg/kg IV/IO, max 0.5 mg, MR x1 in 5 min (given after 3 epinephrine doses). Organophosphate = 0.02 mg/kg IV/IO, max 2 mg, then double prior dose q3-5 min for continued SLUDGE/BBB.
Q33
Protocol ReferenceP-117 Activated Charcoal: Adult = 50 gm PO. Peds = 1 gm/kg PO, max 50 gm. Note: P-117 also lists a pediatric half-dose column at 0.5 gm/kg, max 25 gm for certain situations.
Q34
Protocol ReferenceP-117 Normal Saline Bolus: Peds = 20 mL/kg IV/IO, max single bolus 500 mL.
Q35
Protocol ReferenceP-117 Ondansetron Peds: <6 months = contraindicated. 6 months–3 years = 2 mg IM/IV/ODT. >3 years = 4 mg IM/IV/ODT. Adult = 4 mg IV/IM/ODT, MR x1 in 10 min.
02Sec
Section 2 of 5
Indications & Contraindications
Identify correct indications and absolute contraindications for each medication.
Q36
Protocol ReferenceP-115 NTG Contraindications: (1) Erectile dysfunction or pulmonary hypertension medications within last 48 hours; (2) Suspected intracranial bleed. SBP <100 is a conditional caveat, not a listed contraindication — it triggers dosing guidance. Age is not a contraindication.
Q37
Protocol ReferenceP-115 Ketamine Contraindications: Sedation, dissociative dose ranges, and pregnancy with pain from active labor. Also note: not indicated for pediatrics. Standing order requirements: ≥15 y/o, GCS 15, not pregnant, no alcohol/drug intoxication.
Q38
Protocol ReferenceP-115 Adenosine Contraindications: Second- or third-degree AV block (without pacemaker) and sick sinus syndrome.
Q39
Protocol ReferenceP-115 Albuterol Indications: Respiratory distress (non-cardiac, anaphylaxis, and burns), suspected hyperkalemia, and specific crush injuries. Croup = INCORRECT; protocol states albuterol is ineffective in croup and should be avoided.
Q40
Protocol ReferenceP-115 / S-145 Buprenorphine-Naloxone Contraindications: Methadone use within last 10 days, lack of withdrawal signs/symptoms, severe medical illness (sepsis, respiratory distress), altered mental status, <16 years of age. Age 17 = ok; COWS ≥8 is required for treatment.
Q41
Protocol ReferenceP-115 TXA Contraindications: Isolated severe head injury, thromboembolic event within 24 hours (stroke, MI, DVT, PE), potential need for reimplantation, and mechanism of injury or delivery MORE than 3 hours prior to EMS care.
Q42
Protocol ReferenceP-115 Calcium Chloride Indications: Suspected hyperkalemia, calcium channel blocker overdose, and specific crush injuries. Beta blocker OD is treated with Glucagon, not CaCl2.
Q43
Protocol ReferenceP-115 Ondansetron Contraindications: Known or suspected long QT syndrome AND <6 months of age. A 4-month-old falls under the age contraindication. A 7-month-old is acceptable. Both the 4-month-old AND the long QT adult (answer D) are contraindicated — but the 4-month-old is the single best answer as it's the most absolute age contraindication.
Q44
Protocol ReferenceP-115 Naloxone and S-127 PEA: Naloxone is NOT authorized in cardiac arrest. This is explicitly stated in both the medication list and the cardiac arrest protocol.
Q45
Protocol ReferenceP-115 Lidocaine Contraindications: Cardiac pre-excitation syndromes — e.g., Wolff-Parkinson-White (WPW) syndrome and Lown-Ganong-Levine (LGL) syndrome.
03Sec
Section 3 of 5
Special Considerations
Critical notes, warnings, mixing instructions, and scope-of-practice considerations.
Q46
Protocol ReferenceMixing: Remove 1 mL NS from 10 mL NS syringe → Add 1 mL of epi 1:10,000 (0.1 mg/mL) to 9 mL NS = 10 mL total at 0.01 mg/mL (10 mcg/mL). Administer 1 mL IV/IO doses, titrate to SBP ≥90 mmHg, MR q3 min.
Q47
Protocol ReferenceP-115 Naloxone Scope: EMT = IN only. AEMT = IN/IM only. Paramedic = IN/IM/IV. EMTs may also assist family/friends to medicate with patient's prescribed naloxone in symptomatic suspected opioid OD.
Q48
Protocol ReferenceBoth Amiodarone (P-115) and Ketamine (P-115) explicitly state: "Do not infuse with Ringer's lactate solution."
Q49
Protocol ReferenceP-115 CaCl2 Notes: Confirms all A-D. Option E is WRONG — they must NEVER be mixed together; flush with ≥10 mL NS between administrations or use separate IV lines.
Q50
Protocol ReferenceP-115 Epi 1:1,000 Notes: "Inadvertent IV injection of usual IM formulation and dose constitutes a 10-fold overdose that can result in sudden and severe hypertension and cerebral hemorrhage." Always confirm route before injection.
Q51
Protocol ReferenceP-115 Ondansetron Notes: "May cause serotonin syndrome if co-administered with selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, citalopram, escitalopram, paroxetine."
Q52
Protocol ReferenceP-115 Atropine Notes: "In organophosphate poisoning, titrate atropine to SLUDGE/BBB signs/symptoms, NOT to tachycardia." Tachycardia is an expected side effect of atropine — do not use it as the endpoint.
Q53
Protocol ReferenceP-115 Activated Charcoal Contraindications: Caustic agents, hydrocarbons, or liquid ingestions (e.g., alcohols). Charcoal also does not effectively bind metals (iron, lithium), electrolytes (potassium, magnesium), or acids/alkalis.
04Sec
Section 4 of 5
Treatment Protocols
S-series adult and pediatric protocols — correct sequence and decision points.
Q54
Protocol ReferenceS-122 Anaphylaxis ALS: After epi IM — Diphenhydramine 50 mg IV/IM. THEN if respiratory involvement: Albuterol/Levalbuterol 6 mL nebulizer MR + ipratropium 2.5 mL added to FIRST dose. Push-dose epi is for severe/refractory anaphylaxis.
Q55
Protocol ReferenceS-127 VF/pVT: "Epinephrine 1:10,000 1 mg IV/IO q3-5 min — BEGIN AFTER SECOND DEFIBRILLATION." Not after the first shock.
Q56
Protocol ReferenceS-127 TOR on SO requires ALL 6 criteria: asystole only, unwitnessed, no bystander CPR, no defibrillation, no ROSC, ≥20 min on scene. Age is not listed as a criterion. Excludes: drowning, hypothermia, trauma, electrocution.
Q57
Protocol ReferenceS-139 Trauma: "Do not administer epinephrine" in traumatic cardiac arrest. This applies to both adult (S-139) and pediatric (S-169) traumatic cardiac arrest protocols.
Q58
Protocol ReferenceS-143 Sepsis: Initial 500 mL fluid bolus is given "regardless of initial BP or lung sounds" if ≥2 sepsis criteria are met. Subsequent boluses require no rales OR SBP <90 mmHg (MR x2).
Q59
Protocol ReferenceS-123 ALS: Symptomatic hyperglycemia — 500 mL fluid bolus IV/IO if BS ≥350 mg/dL or reads "high," if no rales MR x1.
Q60
Protocol ReferenceS-134 Charcoal Indications: 1. Acetaminophen, 2. Colchicine, 3. Beta blockers, 4. Calcium channel blockers, 5. Salicylates, 6. Sodium valproate, 7. Oral anticoagulants, 8. Paraquat, 9. Amanita mushrooms, 10. Poison Control recommendation. Alcohols (isopropyl) are a CONTRAINDICATION.
Q61
Protocol ReferenceS-133 Routine Delivery: "Wait 60 seconds after delivery, then clamp and cut cord between clamps."
Q62
Protocol ReferenceS-127 / P-115 Atropine: "May omit atropine in bradycardic patients unlikely to have clinical benefit (e.g., heart transplant patients, second-degree type II, or third-degree heart block)."
Q63
Protocol ReferenceS-127 ECPR Criteria: Time interval from cardiac arrest to arrival at ECPR receiving center ≤45 minutes. Also requires: age 18-70, witnessed arrest, CPR within 5 min, refractory VF/pVT after ≥2 shocks, mechanical compression device.
Q64
Protocol ReferenceS-139 Crush Injury: Prior to release — 1,000 mL fluid bolus + NaHCO3 1 mEq/kg IV/IO + CaCl2 1 gm IV/IO over 30 sec + continuous albuterol/levalbuterol 6 mL nebulizer. TXA is not indicated for crush injuries (it's for hemorrhage/postpartum).
Q65
Protocol ReferenceS-141 Pain Management: Ketamine for "moderate to severe pain (score ≥5)" with all SO requirements met: ≥15 y/o, GCS 15, not pregnant, no alcohol/drug intoxication. Acetaminophen covers 1-10; fentanyl/morphine cover 4-10.
05Sec
Section 5 of 5
Emergency Indicators
Recognizing what signs, symptoms, and findings indicate specific emergencies per San Diego EMS protocols.
Q66
Protocol ReferenceS-144 BE-FAST: B=Balance (unsteadiness, ataxia), E=Eyes (blurred/double or loss of vision), F=Face (unilateral droop), A=Arms and/or legs (unilateral weakness/drift/drop), S=Speech (slurred, word-finding difficulty, absent), T=Time (accurate last known well time).
Q67
Protocol ReferenceS-143 Sepsis: ≥2 of the following with infection history: (1) Temp ≥100.4°F or <96.8°F, (2) HR ≥90, (3) RR ≥20 or EtCO2 <25 mmHg, (4) Altered LOC, (5) SBP <90 mmHg. All 5 are valid criteria.
Q68
Protocol ReferenceS-150 ChemPack / S-134: SLUDGE = Salivation, Lacrimation, Urination, Defecation, Gastrointestinal distress, Emesis. BBB = Bronchorrhea, Bronchospasm, Bradycardia.
Q69
Protocol ReferencePediatric Hypotension Formula (S-163, S-168, S-169): For 1-10 years: SBP <70 mmHg + (2 × age in years). Age 5: 70 + (2×5) = 80 mmHg. So SBP <80 mmHg = hypotensive for a 5-year-old.
Q70
Protocol ReferenceS-100.2 ALS Transport: A-D, F = ALS required. E = EXCEPTION: BLS transport allowed if single therapeutic naloxone given without anticipated repeat doses (also applies to single-dose ondansetron, glucagon, dextrose, acetaminophen).
Q71
Protocol ReferenceS-163 Pediatric SVT: Infant/child <4 years with HR ≥220 bpm OR child ≥4 years with HR ≥180 bpm. Unstable = SBP below age-based threshold + signs of inadequate perfusion.
Q72
Protocol ReferenceS-145: Buprenorphine-naloxone is indicated for patients ≥16 years with COWS score ≥8. COWS scale: <5=no active withdrawal, 5-12=mild, 13-24=moderate, 25-36=moderately severe, >36=severe withdrawal.
Q73
Protocol ReferenceS-122 Allergic Reaction: Skin signs only (urticaria, erythema, pruritus) = Diphenhydramine 50 mg IV/IM. Epinephrine is reserved for ANAPHYLAXIS (respiratory, cardiovascular, GI, or angioedema involvement).
Q74
Protocol ReferenceS-123 / S-134 ALS Opioid OD: Respiratory depression = RR<12, SpO2<96%, OR EtCO2 ≥40 mmHg. GCS <13 alone is not the listed threshold — though altered LOC may be present.
Q75
Protocol ReferenceS-144 Stroke: "Obtain blood glucose. If blood glucose <60 mg/dL, treat for hypoglycemia." Additionally per S-123 / Dextrose notes: Do NOT administer dextrose to patients with stroke unless hypoglycemia is documented.
Q76
Protocol ReferenceS-133/S-166 Neonatal Resuscitation: Newborn HR <60 → chest compressions at 120/min with a 3:1 compression-to-ventilation ratio. Check pulse q1 min. Stop compressions when HR ≥60.
Q77
Protocol ReferenceS-127 / S-130 Hypothermia: Cardiac arrest with hypothermia → Epinephrine 1:10,000 1 mg IV/IO × 1 ONLY. Also: limit antiarrhythmic medications until temperature ≥86°F / ≥30°C.
Q78
Protocol ReferenceP-115 Ipratropium: Added to the FIRST dose of albuterol/levalbuterol ONLY. Not repeated with subsequent nebulizer doses.
Q79
Protocol ReferenceP-115 Diphenhydramine: Adult = 50 mg IV/IM (administered slow IV). Pediatric = 1 mg/kg IV/IM per drug chart (max 50 mg).
Q80
Protocol ReferenceP-115 Albuterol/Levalbuterol Notes: "Levalbuterol may be substituted for albuterol and can be combined with ipratropium bromide. This substitution option applies to patients ≥6 years of age."
Q81
Protocol ReferenceS-124 (Adults): >20% partial-thickness or >5% full-thickness burns. S-170 (Peds): >10% BSA partial-thickness or >5% BSA full-thickness. Both also include suspected respiratory involvement, circumferential/face/hands/feet/perineum burns, and electrical ≥1,000 volts.
Q82
Protocol ReferenceS-127 Stable VT: Amiodarone 150 mg in 100 mL NS over 10 min IV/IO MR x1 OR Lidocaine 1.5 mg/kg IV/IO MR at 0.5 mg/kg q5 min to max 3 mg/kg. Synchronized cardioversion for unstable VT.
Q83
Protocol ReferenceS-130 Environmental: "Defibrillation attempts may be unsuccessful during rewarming until temperature ≥86°F / ≥30°C." Continue rewarming efforts; limit epi to 1 dose and withhold antiarrhythmics until temp ≥30°C.
Q84
Protocol ReferenceS-134 Beta Blocker OD: Glucagon 1-5 mg IV, MR 5-10 min, for a total of 10 mg. Calcium channel blocker OD (SBP <90 mmHg) = CaCl2 1 gm IV/IO. TCA OD with cardiac effects = NaHCO3 1 mEq/kg.
Q85
Protocol ReferenceS-133 Postpartum Hemorrhage: "If estimated blood loss ≥500 mL and within 3 hours of delivery, tranexamic acid 1 gm/10 mL IV/IO, in 50-100 mL NS, over 10 min."
Q86
Protocol ReferenceS-131 / S-135: "Dialysis catheter (Vascath) contains concentrated dose of heparin, which must be ASPIRATED prior to infusion." Aspirate 5 mL first to prevent heparin bolus causing systemic anticoagulation.
Q87
Protocol ReferenceS-163 Pediatric Unstable Bradycardia: If no HR increase after 30 sec BVM → CPR + Epinephrine 1:10,000 per drug chart IV/IO MR x2 q3-5 min. ATROPINE comes AFTER 3 doses of epinephrine (per drug chart, MR x1 in 5 min). Unlike adults, epi comes before atropine in peds.
Q88
Protocol ReferenceS-144 Stroke: "Keep head of bed (HOB) at 15° elevation. If SBP <120 mmHg and patient tolerates, place HOB flat." Avoid lowering below 15° unless hypotensive.
Q89
Protocol ReferenceS-142 / P-115 Midazolam: "Administration in patients with alcohol intoxication can cause respiratory depression. Consider a lower dose or avoiding use." Not absolutely contraindicated — clinical judgment required.
Q90
Protocol ReferenceS-127 ROSC: Goal EtCO2 = 40 mmHg. During CPR: rapid rise = check pulse; EtCO2 >0 allows airway placement without interruption. S-139/S-169 Trauma: Maintain EtCO2 35-45 mmHg.
Q91
Protocol ReferenceP-115 / P-117 Acetaminophen IV: Contraindicated in patients <2 years of age. P-117 Pediatric Drug Chart: Grey column (newborn–6 months) = "DO NOT ADMINISTER." Red/subsequent columns (≥2 years) = 15 mg/kg, max 1 gm.
06Sec
Exam Complete
Your Results
San Diego County EMS Protocol Exam 2025–2026
—
Questions Correct
—
Percentage Score
—
Questions Answered
—
Letter Grade
Score Breakdown by Section